A B S T R A C T Cytomegalovirus (CMV) is a major pathogen in the compromised host where many infections result from activation of latent virus. Because latent CMV infection has been difficult to study in humans, murine models have been developed and investigated. Here, we describe the events involved in activation of latent murine CMV (MCMV) from spleen explants in vitro. Infectious virus was no longer detectable in murine organs 4 mo after inoculation of 105 plaque-forming units of MCMV. 8-10 d after establishment of spleen explants, phagocytic macrophages covered 70-80% of the surface of tissue culture dishes, and lymphocytes were continuously released, reaching titers of 106 cells/ml. MCMV was produced spontaneously after 12-18 d from spleen explant cultures of 33 of 34 mice. Virus replicated to titers above 104 plaque-forming units/ml, remained at that level for 4-5 wk, and gradually disappeared as macrophages were lysed. Although MCMV was shown to be replicating in macrophages, these cells were never found to be the source of latent virus. Cell separation studies indicated that latent virus was initially released from 70% of lymphocyte cultures and was associated with the B cell enriched fraction. We conclude that MCMV establishes nonreplicating dormant infection in B lymphocytes, activates from these cells in spleen explant cultures, and is augmented in titer by replication in permissive macrophages.
INTRODUCTION
The ability of herpesviruses to establish dormant or latent infections in the host is an important biological characteristic (1) . In some instances, the tissue sites or even the specific cells that harbor latent virus have been identified experimentally. Thus, herpes simplex virus establishes latent infection in neurons of sensory ganglia (2) (3) (4) (5) (6) , whereas the Epstein-Barr virus persists in a nonreplicating state in human B lymphocytes (7) . In the case of cytomegalovirus (CMV)', however, the evidence that latent infection occurs is largely circumstantial, and the tissue or cellular sites maintaining latent virus in humans have not been identified conclusively (8) (9) (10) . Infection is apparently transmitted from donor to recipient by blood transfusion or organ transplantation and may also be reactivated in pregnancy or in states of compromised immunity (10) (11) (12) (13) (14) (15) . Nevertheless, experimental attempts to recover latent virus from blood leukocytes or from transplanted donor renal allograft tissue have not been successful (16) (17) (18) (19) .
Definition and characterization of the latent viral state is fundamental to a basic understanding of the pathogenesis of CMV infection, especially since studies of live attenuated vaccine have now been initiated (20) (21) (22) . Because (24) (25) (26) .
Establishment of latent MCMV infection. The techniques and criteria used in this laboratory to establish and define latent infection of mice with MCMV have been presented previously (27) . Female C3H/St mice, 4-6 wk old, were inoculated intraperitoneally with 1 X 105 plaque-forming units of virulent MCMV. 16 wk after inoculation, no infectious MCMV could be detected in the tissues of these animals except for 3-8% of mice with persistent low-level virus replication in the salivary glands (26) . Animals with active viral infection were excluded from experiments after assay of surgically-resected salivary gland tissue for infectious MCMV in mouse embryo cell culture (23 Separation of spleen cell populations. In experiments where suspensions of spleen cells were required, the spleen was bisected with scissors. The pulp of each spleen half was then gently extruded from the capsule using a tuberculin syringe containing 1 ml of RPMI medium and fitted with a 26-gauge needle. The extruded spleen contents were gently dissociated by pipetting and the resulting cells were washed three times in fresh medium by centrifugation at 300 g for 10 min. After adjustment to a concentration of -5 X 106 cells/ml as determined in a hemocytometer, the cell suspensions were incubated in 6-12 16-mm-Diam wells of tissue culture plastic trays (Co-star 3524, Data Packaging). Before inoculation into the wells, cell viability was shown to be -95% by the trypan-blue dye exclusion method (27) . Because the time required for spleen macrophages to adhere to glass or plastic surfaces is substantially greater than for peritoneal exudate cells (28) , the cultures were left undisturbed for the first 72 h. At that time, nonadherent lymphocytes were removed, resuspended in fresh medium, and either cultivated alone or cultivated along with virus-susceptible syngeneic mouse embryo cells, depending on the purposes of the experiment.
Cultures of spleen cell suspensions enriched for bone marrow-derived lymphocytes (B cells) or for thymus-derived lymphocytes (T cells) were required for certain experiments. Here, three different cell enrichment procedures were employed after removal of macrophages by surface adherence for 72 h. Enriched B cell subpopulations were prepared by treatment of lymphocytes in suspension with a 1:10 dilution of rabbit anti-Thy 1.2 serum (anti-C3H Thy 1.2, Litton Bionetics, Kensington, MD) for 60 min at 37°C. Subsequently, 40 U of CH 50 guinea pig complement (Cordis Laboratories Inc., Miami, FL) were added before a second 60-min incubation period (29) . Less than 2% residual T cells remained after this procedure, as determined by sheep erythrocyte rosetting studies and by specific immunofluorescence staining with fluorescein isothiocyanate-conjugated monoclonal anti-Thy Identification of macrophages. Macrophages were identified morphologically by staining with hematoxylin and eosin, and by characteristic ultrastructural features (32) . To test phagocytic function, the monolayers of adherent cells were incubated with 0.02 ml of a 10% suspension of 1.1 um polystyrene (latex) particles for 45 min at 37°C. After three washes with phosphate-buffered saline to remove extracellular particles, the monolayers were examined microscopically and scored for ingestion of latex beads. In addition, macrophages were identified by staining for lysozyme content using specific rabbit antibody conjugated with horseradish peroxidase (33) .
Electron microscopy. To prepare spleen explant cultures for ultrastructural examination, nonadherent cells were aspirated and then pelleted by low speed centrifugation in medium. Subsequently, macrophages were gently scraped from the surface of cell culture wells using a rubber-tipped glass rod and then also pelleted by centrifugation. Cell pellets were dehydrated, fixed in glutaraldehyde, embedded in Epon, and thin-sectioned for microscopy using standard ultrastructural procedures (34 (Fig. 3 A) . The majority of virions were defective, with only 20-25% containing central dense cores. Viral particles were eventually demonstrable in -10-15% of macrophages by ultrastructural analysis 24 d after the establishment of spleen explants. Virions were clearly associated with lytic infection of many of these cells (Fig. 3 B) . In no instance were viral nucleocapsids or defective particles detected in the nucleus or cytoplasm of lymhocytes examined by electron microscopy.
Although these observations indicated that macrophages were lytically infected with MCMV after viral activation, the source of latent virus 24 cultures established in this manner (Table I ). The remaining macrophage cultures were maintained without mouse embryo cell overlay for 28 d, and the culture fluids were assayed for infectious virus every other day. Again, no MCMV was detected. These macrophages were then overlaid with mouse embryo cells. No MCMV was detected after observation for an additional 28 d.
That latent MCMV did not activate in macrophage cultures suggested that these cells were not the source of latent virus. Nevertheless, the possibility remained that the presence of lymphocytes was in some way a requirement for activation of MCMV latent within macrophages. Therefore, crossover experiments were performed in which macrophages derived from spleens of six latently infected mice were co-cultured for 30 d with spleen lymphocytes from six uninfected mice, and vice versa. Under these conditions, activated MCMV could be recovered only when lymphocytes from latently infected animals were co-cultivated with macrophages from either latently infected or uninfected animals. However, MCMV was never detected in macrophage cultures established from latently infected mice maintained in the presence of lymphocytes from uninfected animals.
Taken together, these experiments suggested that, although macrophages underwent lytic viral infection in the spleen explant cultures and were responsible for production of infectious virus, they were not the cells harboring latent MCMV.
To determine whether spleen lymphocytes were latently infected, these cells were cultivated alone or along with virus-susceptible mouse embryo fibroblasts after removal of splenic macrophages by adherence. The lymphocyte cultures were maintained for 30 fter removal of macrophages by adherence for 72 h, spleen lymphocytes from three or four latently infected mice were pooled before separation into enriched cell populations by the three procedures noted. Subsequently, cell concentrations were adjusted to 5 X 106/ml and co-cultivated with mouse embryo cells in six to twelve replicate wells. 
DISCUSSION
To summarize these results, spleen explants were established from mice that had been infected [16] [17] [18] [19] [20] (49) .
Despite strong clinical and epidemiologic evidence that CMV causes latent infections in humans, a direct experimental demonstration of the phenomenon has been most difficult. The cells or tissues that have been strongly implicated include peripheral blood leukocytes (11, 18) , kidney (13, 14) , colon (50) , and heart (51) . In the murine model, definition of the sites of viral latency and elucidation of host and viral factors involved in maintenance and reactivation of latent virus will continue to provide valuable insight relevant to human investigation.
